Superworth

InfuSystem price to book ratio INFU

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
4.7×
10-year median
3.7×
Against its 10-year history
74th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.6× to 15.1×
Peer median
2.6×

InfuSystem's price to book ratio is 4.7× as of Oct 23, 2026.

That is above its ten-year median of 3.7×, higher than on 74% of days in the last ten years.

Over that time it ranged from 0.6× in May 2017 to 15.1× in Mar 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 2.6×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far4.7×2.8×4.7×
20253.3×1.8×4.0×
20243.1×2.3×4.1×
20234.3×3.0×4.7×
20223.8×3.0×7.2×
20217.6×5.9×15.1×
202012.9×5.5×13.1×
20197.5×3.2×7.9×
20183.2×1.0×3.4×
20171.1×0.6×1.1×
20161.1×0.8×1.6×
20151.4×1.3×1.6×
20141.5×1.1×2.0×
20131.1×0.7×1.2×
20120.8×0.8×1.2×
20110.8×0.3×1.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest InfuSystem's size, closest first, today.

CompanyPrice to book ratio
INFUInfuSystem4.7×
UTMDUtah Medical Products1.9×
EMBCEmbectan/m
PDEXPro DEX4.2×
TCMDTactile Systems Technology2.4×
MDXGMimedx2.6×
MOVMovado1.4×
KEQUKewaunee Scientific1.3×
IRMDIradimed10.8×
STAAStaar Surgical3.1×
BVSBioventus5.5×
Peer median2.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on InfuSystem

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.